Draper Lab : All Pages
- Copyright
- Picture Credits
- Accessibility Statement
- A new malaria review article
- New SARS-CoV-2 vaccine paper
- Group Members
- Contact Us
- Simon Draper
- Barney Williams
- 2020 Blood stage getaway
- Jee-Sun Cho
- Working in COVID-19 research: running a vaccine study
- Kirsty McHugh
- Doris Quinkert
- Lloyd King
- Francesca Donnellan
- Angela Minassian
- Carolyn Nielsen
- Sarah Silk
- Mimi Hou
- Fay Nugent
- Kate Skinner
- Susanne Hodgson
- Patries Fisher
- 2019 Summer Picnic
- 2017 Getaway
- Ebola mAbs on Radio Cherwell
- Keystone - Antibodies as Drugs 2020
- 2018 Christmas celebrations
- Research
- Home
- Latest RH5 clinical trial shows promise
- Revealing the immunological detail of protein and viral vector vaccine responses
- Development of vaccines against blood-stage P. Falciparum
- Human antibody response to vaccination
- Development of vaccines against blood-stage P. vivax
- Clinical trials
- Public Engagement
- Malaria vaccine basics
- News
- Publications
- Lana Strmecki
- Congratulations Dr Barney Williams!
- Congratulations Dr Fran Donnellan!
- New study supports RH5 vaccine trials in malaria-endemic regions
- Post-CHMI Celebration, 1st of July 2021
- New paper shedding light on the (lack of) interaction between human basigin and SARS-CoV-2 spike
- Draper group establishes high quality infection model for Plasmodium vivax
- Jo Salkeld
- COVID-19 Vaccine Team Receive Award at 2021 RSPH Awards Ceremony
- HIC-Vac Annual meeting 2021
- BSI congress 2021
- 3Rs Commendation for Draper Group
- New paper describes a novel mechanism for antibody synergy against a malaria vaccine candidate
- Angela Minassian: The Malaria Researcher Leading the COVID Vaccine Trials
- Vacancies
- Congratulations Dr Lawrence Wang!
- Draper Group at the BSP Spring Meeting 2022
- Malaria Vaccine R&D Webinar – GVIRF 2022
- Lawrence T. Wang named a 2022 Paul & Daisy Soros Fellow
- World Malaria Day 2022
- Carolyn attends Keystone Symposium in Hanover, Germany
- First UK B cell meeting
- Oxford Immunology Symposium
- 8th International Conference on Plasmodium vivax Research 2022 (ICPvR)
- Mimi and Angela attend 32nd ECCMID in Lisbon
- Collaborators
- Keystone Symposium - Antibodies As Drugs 2022
- Keystone Symposium - Antibodies As Drugs 2022
- Keystone Symposium - Antibodies As Drugs 2022
- Keystone Symposium - Antibodies As Drugs 2022
- Fran presenting at Keystone Symposium - Antibodies As Drugs 2022
- UK Clinical Vaccine Network Meeting 30 June 2022
- Jordan's presentation at the Oxford/Pirbright B cell meeting
- Kavli Research Refresh Presentations
- Immunotherapies for Infectious Diseases Conference (IIDC), Pavia, Italy
- MSc Thesis Submission Karolina Kwiatkowska
- Jenny Bryant
- Good luck, Makurata!
- 11th Infectious Diseases in Africa (IDA) Symposium in Stellenbosch, South Africa
- 20th Protein Island Matsuyama International Symposium (PIM2022), Matsuyama, Ehime, Japan
- Oxford/ Pirbright B cell Meeting - October 2022
- ICTMM2020 Bangkok
- OptiMalVax Nijmegen, The Netherlands
- “Malaria Prevention: Progress and Prospects” Symposium at BRCCH, Basel
- National Institute of Allergy and Infectious Diseases (NIAID) Malaria Research Program (MRP) Symposium
- Annual Meeting of the American Society of Tropical Medicine and Hygiene (ASTMH) in Seattle
- New Funding Call now open: MRC Impact Accelerator Account (formally CiC) 2022
- World Vaccine Congress Europe 2022
- Draper group retreat 2022 – A welcome break in the forest
- HIC-Vac Annual Meeting 2022
- Carolyn's review published in Front Immunol
- Cassandra Rigby
- EDCTP Multi-Stage Malaria Vaccine Consortium (MMVC) annual meeting in The Gambia
- Christmas Party 2022
- VAC063C Clinical trial paper published in Frontiers in Immunology
- Phage Turners
- EDCTP MIMVaC-Africa Consortium 2023
- VAC089 Trial: Malaria Vaccine Study
- Delayed fractional dosing clinical immunology paper published in JCI Insight
- Unveiling our new Carterra LSA
- Rachel Roberts
- Zi Wei (Wendy) Teo
- Oxford Immunology Symposium 2023
- Dr Jee-Sun Cho & the VAC089 study featured by the NIHR for World Malaria Day
- Draper Group at the BSP Spring Meeting 2023
- VAC086 Trial: Sarah sets up laboratory and conducts training at Fajara station in The Gambia
- Spring 2023 Oxford/Pirbright B cell meeting
- Jo Salkeld features in photoshoot for Telegraph to mark World Malaria Day
- World Malaria Day Symposium at the Johns Hopkins Bloomberg School of Public Health
- 10th Anniversary Symposium of the Vaccine Formulation Institute (VFI)
- Malaria GRC
- Rachel Cowan
- Oxford University open day 2023
- Summer social boat trip!
- Ebola mAbs review
- LEAF Silver Award for the Draper Lab!
- BIO-002 Trial
- Results from P. vivax vaccine efficacy trials VAC071 and VAC079 published in Science Translational Medicine
- Andrew Duncan
- Results from the first RH5 candidate vaccine trial in a malaria-endemic setting, VAC070 published in Med
- BIO-001 Trial: Malaria Vaccine Study
- Volunteer
- Ana Rodrigues
- Amy Boyd
- Anika Luo
- Oxford Mosaic Accessibility Statement
- New preprint on the antigenic landscape of RH5 now available!
- Teaching excellence project award for Susanne, Fran, and Barney
- OptiViVax
- Behind the scenes: developing a new malaria vaccine - Oxford Sparks
- Grand Challenges Annual Meeting (GCAM) 2023
- Inaugural Richard J. Meyer Endowed Lecture at UTA
- ASTMH 2023 Chicago
- HIC-Vac Annual Meeting 2023
- Millie Gladstone
- BIO-004 study
- Paper published in Frontiers in Immunology
- Oxford Cytometry Club Meeting
- Oxford/Pirbright B cell meeting November 2023
- New preprint on the development of an improved blood-stage malaria vaccine
- Draper Lab: Use of cookies on this website
- New trial to study how the human immune system adapts to ‘tolerate’ malaria parasites
- Advancing a malaria vaccine for better global health outcomes - Press Release
- New preprint: Phase Ib clinical trial of our leading malaria vaccine candidate, RH5.1 in Matrix-M, conducted in Tanzania
- Now published in Vaccine: Analysis of the precision of the transgenic P. knowlesi growth inhibition assay for P. vivax vaccine development
- Multilateral Initiative on Malaria (MIM) Society 8th Pan-African Malaria Conference
- Carolyn and Andrew interview on Radio Cherwell re ongoing recruitment for malaria challenge trials
- Now published in Nature Communications - Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex
- Now published in The Lancet ID - Phase Ib clinical trial of our most advanced malaria vaccine candidate, RH5.1 in Matrix-M.
- Draper Group members attend UK Clinical Vaccine Network Annual Conference in Birmingham
- Tom Roberts
- Giacomo Gorini
- New paper published in Cell Reports Medicine
- New paper “Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype” published in Cell
- June Oxford & Pirbright B cell meeting
- Mariola Zaleska
- Molly Jefferies
- Jennifer Kate van Heerden
- Sam Toulmin
- Noah Miller
- Camille Gourjault
- Malaria vaccine RH5.1/Matrix-M is effective in preventing malaria in African children (new preprint)
- Simon's plenary talk at the International Society for Vaccines (ISV) Annual Congress 2024 in Seoul
- Phebe Ekregbesi
- Malaria: Past, Present and Future
- Annual Meeting of the American Society of Tropical Medicine and Hygiene (ASTMH) in New Orleans, USA
- Trial results for first vaccine against blood-stage malaria show it is well-tolerated and offers effective protection
- Anna Huhn